| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |